CompanyGraph
Qianjiang Yongan Pharmaceutical Co. Ltd.
002365 · SZSE · China
chinataurine.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 12.6: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.72%Below 5Y avg (0.92%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
108.3%High
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.08BCNY607.90M · vs all stocks (USD)
Trailing P/E
76.83xRevenue (TTM)
979.49MCNY146.10M · vs all stocks (USD)
Profit Margin
5.45%Beta
0.3170xvs all stocks
52-Week Change
-22.00%vs all stocks
Market Capitalization
4.08BCNY607.90M · vs all stocks (USD)
Enterprise Value
3.15BCNY469.68M · vs all stocks (USD)
Trailing P/E
76.83xForward P/E
16.87xPrice to Sales (TTM)
4.16xPrice to Book (MRQ)
2.00xEnterprise to Revenue
3.21xEnterprise to EBITDA
18.44xGross Margin
28.99%Profit Margin
5.45%Operating Margin
14.49%Return on Assets (TTM)
1.52%Return on Equity (TTM)
2.07%Revenue (TTM)
979.49MCNY146.10M · vs all stocks (USD)
Revenue per Share (TTM)
3.39CNYUpdated Sep 19, 2026Quarterly Revenue Growth
67.10%Gross Profit (TTM)
216.18MCNY32.25M · vs all stocks (USD)
EBITDA (TTM)
91.83MCNY13.70M · vs all stocks (USD)
Net Income (TTM)
53.41MCNY7.97M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
111.50%Operating Cash Flow (TTM)
119.99MCNY17.90M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-41.77MCNY-6.23M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 19, 2026Trailing Annual Dividend Yield
0.72%vs all stocks
5-Year Average Dividend Yield
0.92%vs all stocks
Payout Ratio
108.34%Minority Interest (Equity)
-5.07MCNYFY2025 · Dec 31, 2025Revenue
783.17MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
650.68MCNYFY2025 · Dec 31, 2025Gross Profit
132.48MCNYFY2025 · Dec 31, 2025Operating Income
-2.72MCNY-405.74K · vs all stocks (USD)
Pre-tax Income
9.88MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.69MCNYFY2025 · Dec 31, 2025Net Income
7.19MCNYFY2025 · Dec 31, 2025EBIT
10.82MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
144.96MCNYFY2025 · Dec 31, 2025Research & Development
30.88MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
45.68MCNYFY2025 · Dec 31, 2025Other Operating Expenses
10.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.36MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
941.50KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0777CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0777CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
289.49MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
289.49MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
7.19MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
15.30MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
40.52MCNYFY2025 · Dec 31, 2025Free Cash Flow
-21.39MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
230.59MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
7.19MCNYFY2025 · Dec 31, 2025Other Non-cash Items
941.50KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
39.58MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-7.19MCNYFY2025 · Dec 31, 2025Capital Expenditures
-61.91MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.14BCNYFY2025 · Dec 31, 2025Sale of Investments
1.09BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-120.05MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
15.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-54.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-29.88MCNYFY2025 · Dec 31, 2025Other Financing Charges
-40.79MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-110.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
294.68MSharesUpdated Sep 19, 2026Float Shares
207.60MSharesUpdated Sep 19, 2026% Held by Insiders
29.68%vs all stocks
% Held by Institutions
1.11%vs all stocks
Total Cash (MRQ)
836.03MCNY124.70M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.89CNYUpdated Sep 19, 2026Total Debt (MRQ)
395.18KCNY58.95K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0002xCurrent Ratio (MRQ)
5.25xBook Value per Share (MRQ)
6.92CNYUpdated Sep 19, 2026Total Assets
2.20BCNY328.25M · vs all stocks (USD)
Total Current Assets
1.15BCNYFY2025 · Dec 31, 2025Total Liabilities
218.72MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.05BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
14.79MCNYFY2025 · Dec 31, 2025Total Current Liabilities
203.94MCNYFY2025 · Dec 31, 2025Cash
229.36MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.23MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
230.59MCNYFY2025 · Dec 31, 2025Other Short-term Investments
687.89MCNYFY2025 · Dec 31, 2025Accounts Receivable
116.84MCNYFY2025 · Dec 31, 2025Inventory
90.89MCNYFY2025 · Dec 31, 2025Accounts Payable
115.57MCNYFY2025 · Dec 31, 2025Short-term Debt
750.00KCNYFY2025 · Dec 31, 2025Other Current Liabilities
11.58MCNYFY2025 · Dec 31, 2025Common Stock (Book)
294.68MCNYFY2025 · Dec 31, 2025Retained Earnings
830.81MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.98BCNY295.63M · vs all stocks (USD)
Treasury Stock
40.48MCNYFY2025 · Dec 31, 202552-Week Low
9.82CNYUpdated Sep 19, 202652-Week High
19.90CNYUpdated Sep 19, 202652-Week Change
-22.00%vs all stocks
Beta
0.3170xvs all stocks
50-Day MA
13.68CNYUpdated Sep 19, 2026200-Day MA
13.68CNYUpdated Sep 19, 2026Avg 10-Day Volume
29.59MSharesUpdated Sep 19, 2026Avg 30-Day Volume
38.61MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
0.1800CNYUpdated Sep 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 12.6: safe zoneNotable
Altman Z-Score: 12.60
High earnings qualityNotable
Earnings Quality Score: 0.77
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
FDC Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shattuck Labs Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shanghai Xiao Feng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
476830
Tier 1ProductionApproval-Gated PipelineRule
Beijing Science Sun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CorMedix Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Miracure Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hefei Lifeon Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
IOL Chemicals and Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule